Shiva Kaul
Member

That has nothing to do with Phillips' patent disclosures.

Yes, the problem here isn’t replication or fraud or even financial conflicts. It’s the disconnect between the paper - which sensibly describes...

"Strong" but not "very strong", apparently.

How demure, considering the vast potential of the patent: Groundbreaking. No restrictions are placed on either the origin of these ingredients...

They also screened for comorbidities: Still, you are right: some people can oddly manage to be “healthy” in spite of deficient T. These tail...

The full underlying review describes, in this context, a diligent and insistent FDA:

When treating low T, internists and GPs are supposed to follow this systematic review. Dr. Nichols, what do you think about their methods and...

To be clear, the reference range is drawn from healthy, nonobese men. These data show it's possible to be healthy even with low T, says the GP....

The problem is that uncontextualized, arbitrary statistical “reasoning” has taken precedence over basic cost-benefit analysis. The reference range of...

This is remarkably stupid. Reactive N (Nr) includes a number of compounds, not just ammonia (NH3) from dietary protein, but also nitrate (NO3) and...

Replace twitter.com with nitter.ca or any of these domains.

The FDA now allows pharmacists to distribute Paxlovid without a physician’s prescription. Doctors: thank you for your support throughout these trying...